Australia Markets closed

Genetic Signatures Limited (GSS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.2500-0.0800 (-6.02%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.41
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 31.9650
52-week low 31.0400
50-day moving average 31.4405
200-day moving average 31.3732

Share statistics

Avg vol (3-month) 3100.13k
Avg vol (10-day) 387.79k
Shares outstanding 5143.1M
Implied shares outstanding 6N/A
Float 8129.19M
% held by insiders 135.21%
% held by institutions 132.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)30 June 2021

Profitability

Profit margin 6.19%
Operating margin (ttm)5.38%

Management effectiveness

Return on assets (ttm)1.84%
Return on equity (ttm)3.69%

Income statement

Revenue (ttm)28.38M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)-6.50%
Gross profit (ttm)17.14M
EBITDA 2.61M
Net income avi to common (ttm)1.76M
Diluted EPS (ttm)0.0120
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.12M
Total cash per share (mrq)0.21
Total debt (mrq)399k
Total debt/equity (mrq)0.81
Current ratio (mrq)10.30
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)4.2M
Levered free cash flow (ttm)-2.35M